Free Trial

Inspire Medical Systems (INSP) Competitors

Inspire Medical Systems logo
$146.36 -3.69 (-2.46%)
Closing price 03:59 PM Eastern
Extended Trading
$148.96 +2.60 (+1.77%)
As of 07:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

INSP vs. SOLV, SNN, PEN, STVN, GKOS, NARI, IRTC, BLCO, TMDX, and SLNO

Should you be buying Inspire Medical Systems stock or one of its competitors? The main competitors of Inspire Medical Systems include Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), TransMedics Group (TMDX), and Soleno Therapeutics (SLNO). These companies are all part of the "medical equipment" industry.

Inspire Medical Systems vs.

Inspire Medical Systems (NYSE:INSP) and Solventum (NYSE:SOLV) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.

Solventum has higher revenue and earnings than Inspire Medical Systems. Solventum is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$840.11M5.14$53.51M$2.1767.45
Solventum$8.31B1.52$373.71M$2.1633.72

Inspire Medical Systems received 196 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 61.88% of users gave Inspire Medical Systems an outperform vote while only 7.41% of users gave Solventum an outperform vote.

CompanyUnderperformOutperform
Inspire Medical SystemsOutperform Votes
198
61.88%
Underperform Votes
122
38.13%
SolventumOutperform Votes
2
7.41%
Underperform Votes
25
92.59%

94.9% of Inspire Medical Systems shares are held by institutional investors. 4.1% of Inspire Medical Systems shares are held by company insiders. Comparatively, 0.1% of Solventum shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Inspire Medical Systems presently has a consensus target price of $211.91, indicating a potential upside of 44.79%. Solventum has a consensus target price of $80.29, indicating a potential upside of 10.22%. Given Inspire Medical Systems' stronger consensus rating and higher possible upside, research analysts plainly believe Inspire Medical Systems is more favorable than Solventum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73
Solventum
1 Sell rating(s)
7 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.10

In the previous week, Solventum had 13 more articles in the media than Inspire Medical Systems. MarketBeat recorded 20 mentions for Solventum and 7 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.83 beat Solventum's score of 1.36 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspire Medical Systems
7 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Solventum
15 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Inspire Medical Systems has a net margin of 6.67% compared to Solventum's net margin of 0.00%. Inspire Medical Systems' return on equity of 8.19% beat Solventum's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems6.67% 8.19% 7.09%
Solventum N/A N/A N/A

Summary

Inspire Medical Systems beats Solventum on 14 of the 17 factors compared between the two stocks.

Get Inspire Medical Systems News Delivered to You Automatically

Sign up to receive the latest news and ratings for INSP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INSP vs. The Competition

MetricInspire Medical SystemsSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$4.32B$4.47B$5.35B$19.38B
Dividend YieldN/A43.64%5.22%3.84%
P/E Ratio84.6029.4326.8434.23
Price / Sales5.1467.72391.3934.85
Price / Cash104.4151.0838.2517.51
Price / Book6.296.236.794.69
Net Income$53.51M$68.16M$3.23B$1.02B
7 Day Performance-6.02%18.33%4.07%-1.34%
1 Month Performance1.12%23.04%12.52%9.79%
1 Year Performance-3.98%20.61%16.83%3.27%

Inspire Medical Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INSP
Inspire Medical Systems
4.6758 of 5 stars
$146.36
-2.5%
$211.91
+44.8%
-3.4%$4.32B$840.11M84.60760Positive News
Gap Down
SOLV
Solventum
2.012 of 5 stars
$74.85
+6.6%
$79.00
+5.5%
+20.4%$12.95B$8.25B27.2222,000Positive News
Analyst Upgrade
SNN
Smith & Nephew
2.2231 of 5 stars
$28.43
+0.3%
$28.00
-1.5%
+12.9%$12.45B$5.81B13.1620,100News Coverage
PEN
Penumbra
4.7159 of 5 stars
$296.98
-0.1%
$302.40
+1.8%
+39.5%$11.50B$1.24B873.473,900Positive News
STVN
Stevanato Group
1.2475 of 5 stars
€23.64
-1.5%
N/A+21.2%$7.16B$1.10B50.304,650Positive News
GKOS
Glaukos
4.6427 of 5 stars
$94.57
+5.1%
$134.67
+42.4%
-10.7%$5.40B$404.52M-32.95780News Coverage
Positive News
NARI
Inari Medical
0.5635 of 5 stars
$79.97
flat
$69.22
-13.4%
N/A$4.68B$493.63M-59.24800News Coverage
IRTC
iRhythm Technologies
1.274 of 5 stars
$137.80
+0.1%
$128.55
-6.7%
+52.5%$4.40B$618.59M-37.861,790Positive News
BLCO
Bausch + Lomb
4.2513 of 5 stars
$11.91
+5.6%
$15.50
+30.2%
-19.2%$4.21B$4.83B-13.0812,500
TMDX
TransMedics Group
1.4465 of 5 stars
$118.73
+6.5%
$126.70
+6.7%
-10.0%$4.02B$488.23M126.31210Positive News
SLNO
Soleno Therapeutics
4.8538 of 5 stars
$76.70
-0.1%
$106.78
+39.2%
+59.6%$3.87BN/A-23.1030News Coverage
Positive News

Related Companies and Tools


This page (NYSE:INSP) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners